Alzheimer's disease and the cell cycle

Acta Neurobiologiae Experimentalis

Volumn 64, Issue 1, 2004, Pages 107-112

  Raina, Arun K ^a   Zhu, Xiongwei ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Cell cycle; Neoplasia; Neurodegeneration; Oncogenesis

Indexed keywords

AMYLOID PROTEIN; CHOLINESTERASE; TAU PROTEIN;

ALZHEIMER DISEASE; CELL CYCLE; DISEASE COURSE; DISEASE MARKER; ENZYME INHIBITION; HUMAN; MITOGENESIS; NERVE CELL NECROSIS; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; CELL CYCLE; CELL CYCLE PROTEINS; HUMANS; NEURONS;

EID: 1842450729     PISSN: 00651400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Alonso AC, Grundke-Iqbal I, Iqbal K (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2: 783-787.
2. Arendt T, Holzer M, Grossmann A, Zedlick D, Bruckner MK (1995) Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience 68: 5-18.
3. Arendt T, Rodel L, Gartner U, Holzer M (1996) Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 7: 3047-3049.
4. Arendt T, Holzer M, Gartner U (1998) Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J Neural Transm 105: 949-960.
5. Barni S, Sciola L, Spano A, Pippia P (1996) Static cytofluorometry and fluorescence morphology of mitochondria and DNA in proliferating fibroblasts. Biotech Histochem 71: 66-70.
6. Bowser R, Smith MA (2002) Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. J Alzheimers Dis 4: 249-54
7. Brion JP, Passarier H, Nunez J, Flament-Durand J (1985) Immunologic determinants of tau protein are present in neurofibrillary tangles of Alzheimer's disease. Arch Biol 95: 229-235.
8. Brion JP, Octave JN, Couck AM (1994) Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience 63: 895-909.
9. Curcio F, Ceriello A (1992) Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol 28A:787-790.
10. Ferrari G, Yan CY, Greene LA (1995) N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci 15: 2857-2866.
11. Gerst JL, Raina AK, Pirim I, McShea A, Harris PLR, Siedlak SL, Takeda A, Petersen RB, Smith MA (2000) Altered cell-matrix associated ADAM in Alzheimer disease. J Neurosci Res. 59: 680-684.
12. Giovanni A, Wirtz-Brugger F, Keramaras E, Slack R, Park DS (1999) Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in β-amyloid-induced neuronal death. J Biol Chem 274: 19011-19016.
13. Goedert M, Jakes R, Crowther RA, Six J, Lubke U, Vandermeeren M, Cras P, Trojanowski JQ, Lee VMY (1993) The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci U S A 90: 5066-5070.
14. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (τ) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83: 4913-4917.
15. Harris PL, Zhu X, Pamies C, Rottkamp CA, Ghanbari HA, McShea A, Feng Y, Ferris DK, Smith MA (2000) Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes. Neurobiol Aging 21: 837-841
16. Hirai K, Smith MA, Wade R, Perry G (1998) Vulnerable neurons in Alzheimer disease accumulate mitochondrial DNA with the common 5kb deletion. J Neuropathol Exp Neurol 57: 511.
17. Iqbal K, Zaidi T, Thompson CH, Merz PA, Wisniewski HM (1984) Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol 62: 167-177.
18. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ (1997) Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652.
19. Janicki S, Monteiro MJ (1997) Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I). J Cell Biol 139: 485-495.
20. Janicki SM, Monteiro MJ (1999) Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant. Am J Pathol 155: 135-144.
21. Kanemaru K, Takio K, Miura R, Titani K, Ihara Y (1992) Fetal-type phosphorylation of the tau in paired helical filaments. J Neurochem 58: 1667-1675.
22. Ledoux S, Rebai N, Dagenais A, Shaw IT, Nalbantoglu J, Sekaly RP, Cashman NR (1993) Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. J Immunol 150: 5566-5575.
23. Li J, Xu M, Zhou H, Ma J, Potter H (1997) Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 90: 917-927.
24. Lindwall G, Cole RD (1984) Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem 259: 5301-5305.
25. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23: 134-147.
26. Mattson MP, Guo Q, Furukawa K, Pedersen WA (1998) Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J Neurochem 70: 1-14.
27. McDonald DR, Bamberger ME, Combs CK, Landreth GE (1998) β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 18: 4451-4460.
28. McShea A, Harris PLR, Webster KR, Wahl AF, Smith MA (1997) Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol 150: 1933-1939.
29. McShea A, Wahl AF, Smith MA (1999a) Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. Med Hypotheses 52: 525-527.
30. McShea A, Zelasko DA, Gerst JL, Smith MA (1999b) Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. Brain Res 815: 237-242.
31. Nagy Z, Esiri MM, Smith AD (1997a) Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol 93: 294-300.
32. Nagy Z, Esiri MM, Cato AM, Smith AD (1997b) Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol 94: 6-15.
33. Ogawa O, Lee HG, Zhu X, Raina A, Harris PL, Castellani RJ, Perry G, Smith MA (2003a) Increased p27, an essential component of cell cycle control, in Alzheimer's disease. Aging Cell 2: 105-110.
34. Ogawa O, Zhu X, Lee HG, Raina A, Obrenovich ME, Bowser R, Ghanbari HA, Castellani RJ, Perry G, Smith MA (2003b) Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? Acta Neuropathol (Berl) 105: 524-528.
35. Park DS, Morris EJ, Padmanabhan J, Shelanski ML, Geller HM, Greene LA (1998) Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J Cell Biol 143: 457-467.
36. Perry G, Castellani RJ, Hirai K, Smith MA (1998) Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimer's Disease 1: 45-55.
37. Pogocki D (2003) Alzheimer's b-amyloid peptide as a source of neurotoxic free radicals: the role of structural effects. Acta Neurobiol Exp (Wars) 63: 131-145.
38. Pope WB, Lambert MP, Leypold B, Seupaul R, Sletten L, Krafft G, Klein WL (1994) Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y. Exp Neurol 126: 185-194.
39. Pyo H, Jou I, Jung S, Hong S, Joe EH (1998) Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. Neuroreport 9: 871-874.
40. Raina AK, Monteiro MJ, McShea A, Smith MA (1999a) The role of cell cycle-mediated events in Alzheimer's disease. Int J Exp Pathol 80: 71-76.
41. Raina AK, Takeda A, Smith MA (1999b) Mitotic neurons: a dogma succumbs. Exp Neurol 159: 248-249.
42. Raina AK, Zhu X, Monteiro M, Takeda A, Smith MA (2000a) Abortive oncogeny and cell cycle-mediated events in Alzheimer disease. In: Progress in cell cycle research, Vol. 4 (Eds. L. Meijer, A. Jézéquel and B. Ducommun), Kluwer Academic/Plenum Press, New York, p. 235-242.
43. Raina AK, Zhu X, Rottkamp CA, Monteiro M, Takeda A, Smith MA (2000b) Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res 61: 128-133
44. Smith MA (1998) Alzheimer disease. In: International review of neurobiology, Vol. 42 (Eds. R.J. Bradley and R.J. Harris), Academic Press, New York, p. 1-54.
45. Smith MA, Sayre LM, Monnier VM, Perry G (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci 18: 172-176.
46. Smith TW, Lippa CF (1995) Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J Neuropathol Exp Neurol 54: 297-303.
47. Sousa M, Barros A, Silva J, Tesarik J (1997) Developmental changes in calcium content of ultrastructurally distinct subcellular compartments of preimplantation human embryos. Mol Hum Reprod 3: 83-90.
48. Stewart BW (1994) Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 86: 1286-1296.
49. Struhl G, Greenwald I (1999) Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398: 522-525.
50. Sugano T, Nitta M, Ohmori H, Yamaizumi M (1995) Nuclear accumulation of p53 in normal human fibroblasts is induced by various cellular stresses which evoke the heat shock response, independently of the cell cycle. Jpn J Cancer Res 86: 415-418.
51. Suzuki T, Oishi M, Marshak DR, Czernik AJ, Nairn AC, Greengard P (1994) Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J 13: 1114-1122.
52. Terry RD, Gonatas NK, Weiss M (1964) Ultrastructural studies in Alzheimer's presenile dementia. Am J Pathol 44: 269-297.
53. Vincent I, Rosado M, Davies P (1996) Mitotic mechanisms in Alzheimer's disease? J Cell Biol 132: 413-425.
54. Vincent I, Jicha G, Rosado M, Dickson DW (1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 17: 3588-3598.
55. Wolozin B, Iwasaki K, Vito P, Ganjei JK, Lacana E, Sunderland T, Zhao B, Kusiak JW, Wasco W, D'Adamio L (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274: 1710-1713.
56. Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, Chen HY, Price DL, Van der Ploeg LH, Sisodia SS (1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387: 288-292.
57. Yang Y, Mufson EJ, Herrup K (2003) Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease J Neurosci 23: 2557-2563.
58. Ye Y, Lukinova N, Fortini ME (1999) Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature 398: 525-529.
59. Zhu X, Raina AK, Smith MA (1999) Cell cycle events in neurons: proliferation or death? Am J Pathol 155: 327-329.
60. Zhu X, Raina AK, Boux H, Simmons ZL, Takeda A, Smith MA (2000a) Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int J Dev Neurosci 18: 433-7.
61. Zhu X, Rottkamp CA, Raina AK, Brewer GJ, Ghanbari HA, Boux H, Smith MA (2000b) Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease. Neurobiol Aging. 21: 807-13.